The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors

We analyzed the association between achievement of early complete cytogenetic response (CCyR) and event-free survival (EFS) and overall survival (OS) in patients with newly diagnosed chronic myeloid leukemia in chronic phase treated with imatinib 400 mg (n = 73), or imatinib 800 mg daily (n = 208),...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jabbour, Elias, Kantarjian, Hagop, O'Brien, Susan, Shan, Jenny, Quintas-Cardama, Alfonso, Faderl, Stefan, Garcia-Manero, Guillermo, Ravandi, Farhad, Rios, Mary Beth, Cortes, Jorge
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2011
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3291489/
https://ncbi.nlm.nih.gov/pubmed/21803854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-04-348110
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge